Search for Clinical Trial Results
Camurati-Engelmann Disease - 25 Studies Found
Status | Study |
Completed |
Study Name: Angiotensin II Antagonism of TGF-Beta 1 Condition:
Date: 2006-04-28 Interventions: Drug: Candesartan |
Active, not recruiting |
Study Name: TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC Condition: EBV-positive Nasopharyngeal Carcinoma Date: 2014-02-14 Interventions:
|
Active, not recruiting |
Study Name: Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy Condition: HER2 Positive Malignancies Date: 2009-04-24 Interventions: Biological: TGFBeta resistant HER2/EBV-CTLs Each patient w |
Completed |
Study Name: Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers Condition: Healthy Date: 2008-04-07 Interventions:
|
Withdrawn |
Study Name: Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome Condition: Marfan Syndrome Date: 2011-05-25 Interventions: Other: Blood draw This study includes one blood draw to measure circulating blood levels of TGF-B. |
Completed |
Study Name: Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects Condition: Hypertension Date: 2014-11-28 |
Completed |
Study Name: Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2 Condition:
Date: 2009-02-12 Interventions: Drug: AP 12009 Initial scheme: AP 12009 (trabedersen), dos |
Recruiting |
Study Name: Study of Lymphodepletion Plus Adoptive Cell Transfer With TGF-beta Resistant (DNRII) and NGFR Transduced T-Cells Followed by High Dose Interleukin-2 in Participants With Metastatic Melanoma Condition: Melanoma Date: 2013-09-27 Interventions:
|
Completed |
Study Name: Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis Condition:
Date: 2002-08-12 Interventions: Drug: Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody |
Completed |
Study Name: Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D Condition: SLE Date: 2017-05-13 Interventions:
|